Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

Jacques J. M. van Dongen(Universidad de Salamanca), Claus R. Bartram(Goethe University Frankfurt), Martin Schrappe(University Hospital Schleswig-Holstein), Andrea Biondi(University of Milano-Bicocca), Giuseppe Basso(University of Padua), Klaudia Hettinger(St Anna Children's Hospital), Giovanni Cazzaniga(University of Milano-Bicocca), Marianne AC de Bruijn(Erasmus University Rotterdam), Wolfgang Ludwig(Centre National de la Recherche Scientifique), Lilly Corral(Azienda Ospedaliera San Gerardo), Giuseppe Masera(Azienda Ospedaliera San Gerardo), Anna Berg(Stichting Kinderoncologie Nederland), Marja J. Pongers-Willemse(Erasmus University Rotterdam), Willem A. Kamps(Pediatric Oncology Group), Hansjörg Riehm(Medizinische Hochschule Hannover), Elisabeth R. van Wering(Stichting Kinderoncologie Nederland), E. Renate Panzer-Grümayer(St Anna Children's Hospital), Helmuth Gadner(St Anna Children's Hospital), Wim C.J. Hop, Taku Seriu, Frank Stolz(St Anna Children's Hospital)
The Lancet
November 1, 1998
10.1016/s0140-6736(98)04058-6
Cited by 964

Related Papers

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
|Nature|2012|1.6k
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
|Cell|2011|1.4k
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
|The Lancet Oncology|2009|1k